论文部分内容阅读
目的:探讨新生儿黄疸采用药的联合蓝光治疗的临床效果。方法:本次共选取80例新生儿病理性黄疸患儿作研究对象,随机分组就单纯蓝光治疗(对照组)与在此基础上联合茵栀黄口服治疗(观察组)预后进行比较。结果:观察组选取病例临床总有效率为97.5%,明显高于对照组80%,差异有显著统计学意义(P<0.05)。两组治疗前胆红素水平无明显差异,治疗后观察组胆红素每日下降值明显高于对照组,胆红素降至正常时间明显早于对照组,差异均有统计学意义(P<0.05)。结论:新生儿黄疸在蓝光照射治疗的基础上,加用茵栀黄口服,效果较为显著,无明显不良反应,且具较高安全性,使用方便,使预后获得明显改善,具有较高的应用价值。
Objective: To investigate the clinical effect of neonatal jaundice combined with blue light therapy. Methods: A total of 80 neonates with pathologic jaundice were enrolled in this study. The patients were randomly divided into two groups: the control group and the control group, Yinzhihuang oral treatment group (observation group). Results: The total clinical effective rate in the observation group was 97.5%, which was significantly higher than that in the control group (80%) (P <0.05). The bilirubin levels in the two groups had no significant difference before treatment. After treatment, the daily decline of bilirubin in the observation group was significantly higher than that in the control group, and the time to normalization of bilirubin was significantly earlier than that in the control group (P <0.05). Conclusion: Neonatal jaundice on the basis of blue light irradiation, plus Yinzhihuang oral administration, the effect is more obvious, no obvious adverse reactions, and with high safety, easy to use, the prognosis was significantly improved, with a higher application value.